10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Active, not recruitingOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

June 27, 2005

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus 1% cream

Trial Locations (1)

19104

Registry, Philadelphia

All Listed Sponsors
collaborator

Clinical Research Computing Unit (University of Pennsylvania)

OTHER

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00568997 - 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus | Biotech Hunter | Biotech Hunter